Viewing StudyNCT03597282



Ignite Creation Date: 2024-05-06 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03597282
Status: TERMINATED
Last Update Posted: 2020-09-03
First Post: 2018-07-13

Brief Title: A Personal Cancer Vaccine NEO-PV-01 and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
Sponsor: BioNTech US Inc
Organization: BioNTech SE

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Keywords:
Name View
Peptide View
Checkpoint Inhibitor View
Immunotherapy View
Personalized Vaccine View
Neoantigen View
POLY-ICLC View